In the SLE subgroup, a higher positivity of anti-cardiolipin IgG (16.1%), anti-cardiolipin IgM (12.9%), and anti-βGP1 (16.1%) was found in Group A compared with that in the other two groups. This evidence concerns the gene CD40LG and systemic lupus erythematosus.